Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
2,253
+34
+2% +$3.1K 0.05% 129
2026
Q1
$228K Sell
2,219
-50
-2% -$5.65K 0.06% 117
2025
Q4
$284K Hold
2,269
0.07% 106
2025
Q3
$304K Sell
2,269
-104
-4% -$13.7K 0.08% 105
2025
Q2
$323K Hold
2,373
0.09% 100
2025
Q1
$315K Sell
2,373
-99
-4% -$12.6K 0.09% 100
2024
Q4
$280K Sell
2,472
-70
-3% -$8.09K 0.08% 108
2024
Q3
$290K Sell
2,542
-80
-3% -$8.78K 0.09% 106
2024
Q2
$272K Sell
2,622
-90
-3% -$9.54K 0.09% 105
2024
Q1
$308K Hold
2,712
0.1% 105
2023
Q4
$299K Hold
2,712
0.1% 112
2023
Q3
$263K Hold
2,712
0.1% 125
2023
Q2
$296K Sell
2,712
-10
-0.4% -$1.07K 0.12% 99
2023
Q1
$276K Hold
2,722
0.12% 101
2022
Q4
$299K Buy
2,722
+50
+2% +$5.18K 0.12% 110
2022
Q3
$259K Hold
2,672
0.12% 110
2022
Q2
$290K Hold
2,672
0.13% 103
2022
Q1
$312K Buy
2,672
+10
+0.4% +$1.24K 0.13% 109
2021
Q4
$375K Hold
2,662
0.15% 103
2021
Q3
$314K Sell
2,662
-61
-2% -$7.49K 0.13% 104
2021
Q2
$316K Hold
2,723
0.13% 104
2021
Q1
$326K Buy
+2,723
New +$323K 0.14% 105

Other funds holding ABT

Navalign LLC's ABT Position: Q2 2026 in Review

Navalign LLC increased its Abbott (ABT) stake by 1.5% in Q2 2026, buying an estimated $3.1K and bringing the position to 2,253 shares worth $204K. The position accounts for 0.05% of the portfolio, ranked #129.

Navalign LLC first reported a position in ABT in Q1 2021 and has held it in 22 quarters since. The position peaked at $375K in Q4 2021. 1,892 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Navalign LLC held 2,253 shares of Abbott worth $204K as of Q2 2026.
  • Navalign LLC bought 34 Abbott shares in Q2 2026, an estimated $3.1K.
  • Abbott made up 0.05% of Navalign LLC's portfolio in Q2 2026, its #129 holding.
  • Navalign LLC first reported a position in Abbott in Q1 2021 and has held it in 22 quarters since.
  • Navalign LLC's Abbott position peaked at $375K in Q4 2021.
  • 1,892 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.